These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 26670792

  • 21. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M, Fan L, Yeatts SD, Jeromin A, Vos PE, Wagner AK, Wolf BJ, Pauls Q, Lunney M, Merck LH, Hall CL, Palesch YY, Silbergleit R, Wright DW.
    J Neurotrauma; 2019 Oct 15; 36(20):2863-2871. PubMed ID: 30794101
    [Abstract] [Full Text] [Related]

  • 22. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT, TRACK-TBI Investigators.
    J Neurotrauma; 2014 Jan 01; 31(1):19-25. PubMed ID: 23865516
    [Abstract] [Full Text] [Related]

  • 23. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S, Winer JL, Berkner J, Chan LA, Denson JL, Maxwell JR, Yang Y, Sillerud LO, Tasker RC, Meehan WP, Mannix R, Jantzie LL.
    J Neurosurg Pediatr; 2016 Jun 01; 17(6):739-55. PubMed ID: 26894518
    [Abstract] [Full Text] [Related]

  • 24. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S, Kobeissy F, Vestri A, Hayes RL, Kochanek PM, Berger RP.
    Sci Rep; 2016 Jun 20; 6():28203. PubMed ID: 27319802
    [Abstract] [Full Text] [Related]

  • 25. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
    Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, Gunnar Brolinson P, Büki A, Chen JY, Christenson RH, Hack D, Huff JS, Johar S, Jordan JD, Leidel BA, Lindner T, Ludington E, Okonkwo DO, Ornato J, Peacock WF, Schmidt K, Tyndall JA, Vossough A, Jagoda AS.
    Lancet Neurol; 2018 Sep 20; 17(9):782-789. PubMed ID: 30054151
    [Abstract] [Full Text] [Related]

  • 26. Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats.
    Hoane MR, Akstulewicz SL, Toppen J.
    J Neurotrauma; 2003 Nov 20; 20(11):1189-99. PubMed ID: 14651806
    [Abstract] [Full Text] [Related]

  • 27. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM, Schloemann DT, Papa L, Fucetola RP, Bazarian J, Lindburg M, Welch RD.
    Acad Emerg Med; 2017 Jun 20; 24(6):710-720. PubMed ID: 28170122
    [Abstract] [Full Text] [Related]

  • 28. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR, Sheng X, Niedzwecki CM, Bennett KS, Morita DC, Zielinski B, Schober ME.
    J Neurosurg Pediatr; 2018 Oct 20; 22(4):369-374. PubMed ID: 29957142
    [Abstract] [Full Text] [Related]

  • 29. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS, Posti JP, Runtti H, Newcombe VF, Outtrim J, Katila AJ, Frantzén J, Ala-Seppälä H, Kyllönen A, Maanpää HR, Tallus J, Hossain MI, Coles JP, Hutchinson P, van Gils M, Menon DK, Tenovuo O.
    World Neurosurg; 2016 Mar 20; 87():8-20. PubMed ID: 26547005
    [Abstract] [Full Text] [Related]

  • 30. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P, Politis A, van der Merwe A, Moore B, Ekanayake V, Lippa SM, Chou YY, Pham DL, Butman JA, Diaz-Arrastia R, Zetterberg H, Blennow K, Gill JM, Brody DL, Chan L.
    Neurology; 2020 Aug 11; 95(6):e623-e636. PubMed ID: 32641529
    [Abstract] [Full Text] [Related]

  • 31. Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy.
    Kochanek PM, Bramlett HM, Dixon CE, Shear DA, Dietrich WD, Schmid KE, Mondello S, Wang KK, Hayes RL, Povlishock JT, Tortella FC.
    J Neurotrauma; 2016 Mar 15; 33(6):513-22. PubMed ID: 26439468
    [Abstract] [Full Text] [Related]

  • 32. Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
    Korley F, Pauls Q, Yeatts SD, Jones CMC, Corbett-Valade E, Silbergleit R, Frankel M, Barsan W, Cahill ND, Bazarian JJ, Wright DW.
    J Neurotrauma; 2021 Jul 15; 38(14):1953-1960. PubMed ID: 33319651
    [Abstract] [Full Text] [Related]

  • 33. Comprehensive Evaluation of Neuroprotection Achieved by Extended Selective Brain Cooling Therapy in a Rat Model of Penetrating Ballistic-Like Brain Injury.
    Lu XC, Shear DA, Deng-Bryant Y, Leung LY, Wei G, Chen Z, Tortella FC.
    Ther Hypothermia Temp Manag; 2016 Mar 15; 6(1):30-9. PubMed ID: 26684246
    [Abstract] [Full Text] [Related]

  • 34. Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact.
    Swan AA, Chandrashekar R, Beare J, Hoane MR.
    J Neurotrauma; 2011 Mar 15; 28(3):431-40. PubMed ID: 21083416
    [Abstract] [Full Text] [Related]

  • 35. NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury.
    Lu XC, Chen RW, Yao C, Wei H, Yang X, Liao Z, Dave JR, Tortella FC.
    J Neurotrauma; 2009 Jan 15; 26(1):141-54. PubMed ID: 19119917
    [Abstract] [Full Text] [Related]

  • 36. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, Saville B, Tyndall JA, Nash M, Buki A, Barzo P, Hack D, Tortella FC, Schmid K, Hayes RL, Vossough A, Sweriduk ST, Bazarian JJ.
    J Neurotrauma; 2016 Jan 15; 33(2):203-14. PubMed ID: 26467555
    [Abstract] [Full Text] [Related]

  • 37. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
    Liu MC, Akinyi L, Scharf D, Mo J, Larner SF, Muller U, Oli MW, Zheng W, Kobeissy F, Papa L, Lu XC, Dave JR, Tortella FC, Hayes RL, Wang KK.
    Eur J Neurosci; 2010 Feb 15; 31(4):722-32. PubMed ID: 20384815
    [Abstract] [Full Text] [Related]

  • 38. Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans.
    Lippa SM, Gill J, Brickell TA, French LM, Lange RT.
    J Int Neuropsychol Soc; 2021 May 15; 27(5):508-514. PubMed ID: 33161932
    [Abstract] [Full Text] [Related]

  • 39. UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma.
    Morris MC, Bercz A, Niziolek GM, Kassam F, Veile R, Friend LA, Pritts TA, Makley AT, Goodman MD.
    J Surg Res; 2019 Dec 15; 244():63-68. PubMed ID: 31279265
    [Abstract] [Full Text] [Related]

  • 40. Combined hypoxemic and hypotensive insults altered physiological responses and neurofunction in a severity-dependent manner following penetrating ballistic-like brain injury in rats.
    Leung LY, Deng-Bryant Y, Shear D, Tortella F.
    J Trauma Acute Care Surg; 2015 Oct 15; 79(4 Suppl 2):S130-8. PubMed ID: 26406425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.